LXRX vs WYNN · rev $21.8M vs P/E 29, rev $7.14B
Lexicon Pharmaceuticals Inc (LXRX) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Latest reported WYNN revenue for 2025-12-31 was $7.14B. Net income was $327.3M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
LXRX currently screens at market cap $327.2M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the LXRX and WYNN stock pages for the full models.
Not investment advice.